Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)
Clinical trial NCT02036515 · COMPLETED
Trial details
- NCT number
- NCT02036515
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-12
- Primary completion
- 2016-06-06
- Enrollment
- 464
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.